Covered recipient · General Payments record
DOMINIQUE JACOBS
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2022–2024
$2,089.13
- Reported across 55 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,106.79 | 33 |
| Education | $174.98 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $278.68 | 7 |
| Janssen Biotech, Inc. | $248.68 | 5 |
| Amgen Inc. | $186.51 | 10 |
| ABBVIE INC. | $152.74 | 9 |
| Arcutis Biotherapeutics, Inc. | $126.26 | 1 |
| LEO Pharma Inc. | $109.90 | 1 |
| Dermavant Sciences, Inc. | $99.01 | 1 |
| SANOFI-AVENTIS U.S. LLC | $79.99 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.53 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103979764 | CMS |
| ABBVIE INC. | $20.02 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103979766 | CMS |
| ABBVIE INC. | $20.32 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103979768 | CMS |
| ABBVIE INC. | $18.25 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103979770 | CMS |
| ABBVIE INC. | $19.74 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103979772 | CMS |
| ABBVIE INC. | $2.22 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103979774 | CMS |
| ABBVIE INC. | $21.90 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103979776 | CMS |
| ABBVIE INC. | $17.12 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103979778 | CMS |
| ABBVIE INC. | $17.64 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103979780 | CMS |
| Amgen Inc. | $3.85 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117285977 | CMS |
| Amgen Inc. | $19.00 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117285979 | CMS |
| Amgen Inc. | $4.31 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117285981 | CMS |
| Amgen Inc. | $23.57 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117285983 | CMS |
| Amgen Inc. | $4.65 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117285985 | CMS |
| Amgen Inc. | $26.07 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117285987 | CMS |
| Amgen Inc. | $4.00 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117285989 | CMS |
| Amgen Inc. | $3.92 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117285991 | CMS |
| Amgen Inc. | $20.32 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117285993 | CMS |
| Amgen Inc. | $76.82 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117285995 | CMS |
| Arcutis Biotherapeutics, Inc. | $126.26 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121044347 | CMS |
| Dermavant Sciences, Inc. | $99.01 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127883679 | CMS |
| GENZYME CORPORATION | $23.08 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139814151 | CMS |
| GENZYME CORPORATION | $23.08 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139814153 | CMS |
| GENZYME CORPORATION | $23.91 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139814181 | CMS |
| GENZYME CORPORATION | $22.98 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139814207 | CMS |
| GENZYME CORPORATION | $23.55 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139814215 | CMS |
| GENZYME CORPORATION | $139.86 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139814243 | CMS |
| GENZYME CORPORATION | $22.22 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139814259 | CMS |
| Janssen Biotech, Inc. | $14.82 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078550076 | CMS |
| Janssen Biotech, Inc. | $99.75 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078549227 | CMS |
| Janssen Biotech, Inc. | $94.99 | 03/18/2024 | Education | Undisputed | 01/23/2026 | 1078548691 | CMS |
| Janssen Biotech, Inc. | $17.46 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078549932 | CMS |
| Janssen Biotech, Inc. | $21.66 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078549772 | CMS |
| LEO Pharma Inc. | $109.90 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152636109 | CMS |
| SANOFI-AVENTIS U.S. LLC | $79.99 | 11/21/2024 | Education | Undisputed | 01/23/2026 | 1139814255 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.